Barclays Reports 18 Profit Increase Raises FullYear Income Guidance Oura Files Confidentially for IPO Expanding Health Wearable Market Reach Three Decades of Economic Transformation Industries Born from Science Fiction Now Drive Global Growth BP Ousts Chairman Albert Manifold Adding to Boardroom Turmoil at Energy Giant Consumer Price Index Rises 38 in April Exceeding Expectations and Marking Highest Inflation Since May 2023 DeepSeek AI Claims Affordable HighPerformance Model Training Without Advanced Chips M Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Codere Online Q4 2025 Earnings Narrow Loss Surprises on the Downside Stock Edges Up SLN Q4 2024 Earnings Positive EPS Amid Continued Clinical Progress SPRB Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Sentiment ICICI Bank Q1 2026 Earnings Slight EPS Beat Amid Stable Operations DHI Group Inc DHX Q1 2026 Earnings Strong EPS Beat Overshadowed by Revenue Concerns Brookfield Renewable Partners BEP Holds Steady as Renewable Energy Sector Faces Mixed Signals SouthState Bank Corporation SSB Rises Modestly as Shares Hold Above Support Banco Santander Brasil BSBR Edges Higher as Support Holds Steady Space Asset Acquisition Corp SAAQ Holds Steady Near 1033 Ellington Financial EFC Holds Steady Near 1360 as Narrow Range Persists Govt Explores Air Force Transport for NEET Papers Amid Exam Leak Crisis ALTO Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher Amid Operational Improvements FirstService Corporation FSV Holds Steady Near Support as Sector Headwinds Persist MNPR Q1 2026 Earnings NarrowerThanExpected Loss Reflects Controlled Spending Stock Edges Higher Kinsale Capital Group Q1 2026 Earnings Strong EPS Beat Belied by Modest Share Decline Falcons Beyond Global FBYD Q1 2026 Earnings Negative EPS Weighs on Shares SERV Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty GMHS Q1 2026 Earnings Positive EPS Marks a Turnaround Quarter Stock Jumps 656 DOC Q1 2026 Earnings Massive EPS Surprise Highlights Strong Portfolio Management FBRX Q1 2026 Earnings Narrower Loss But Clinical Path Remains Uncertain